These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 9537248)
21. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. Gomella LG; Raj GV; Moreno JG J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297 [TBL] [Abstract][Full Text] [Related]
22. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. Theodorescu D; Frierson HF; Sikes RA J Urol; 1999 May; 161(5):1442-8. PubMed ID: 10210369 [TBL] [Abstract][Full Text] [Related]
23. The application of the RT-PCR method for the staging of the prostate cancer progression. Zummerova A; Labas P; Bohmer D; Blasko M; Polak S; Danisovic L; Repiska V Gen Physiol Biophys; 2010 Dec; 29(4):362-72. PubMed ID: 21156999 [TBL] [Abstract][Full Text] [Related]
24. Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis. Zhang L; Wang CY; Yang R; Shi J; Fu R; Chen L; Klocker H; Zhang J Urol Oncol; 2008; 26(6):634-40. PubMed ID: 18367130 [TBL] [Abstract][Full Text] [Related]
25. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction. Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379 [TBL] [Abstract][Full Text] [Related]
26. Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade. Schmidt B; Anastasiadis AG; Seifert HH; Franke KH; Oya M; Ackermann R Anticancer Res; 2003; 23(5A):3991-9. PubMed ID: 14666708 [TBL] [Abstract][Full Text] [Related]
27. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction. Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840 [TBL] [Abstract][Full Text] [Related]
28. Clinical usefulness of RT-PCR detection of hematogenous prostate cancer spread. Verkaik NS; Schröder FH; Romijn JC Urol Res; 1997; 25(6):373-84. PubMed ID: 9443645 [TBL] [Abstract][Full Text] [Related]
29. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. Ferrari AC; Stone NN; Eyler JN; Gao M; Mandeli J; Unger P; Gallagher RE; Stock R J Natl Cancer Inst; 1997 Oct; 89(20):1498-504. PubMed ID: 9337346 [TBL] [Abstract][Full Text] [Related]
30. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538 [TBL] [Abstract][Full Text] [Related]
31. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer. Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619 [TBL] [Abstract][Full Text] [Related]
32. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296 [TBL] [Abstract][Full Text] [Related]
33. The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer. Olsson CA; De Vries GM; Benson MC; Raffo A; Buttyan R; Cama C; O'Toole K; Katz AE Br J Urol; 1996 Mar; 77(3):411-7. PubMed ID: 8814848 [TBL] [Abstract][Full Text] [Related]
34. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Katz AE; Olsson CA; Raffo AJ; Cama C; Perlman H; Seaman E; O'Toole KM; McMahon D; Benson MC; Buttyan R Urology; 1994 Jun; 43(6):765-75. PubMed ID: 7515202 [TBL] [Abstract][Full Text] [Related]
35. The role of the detection of hematogenous micrometastasis in prostate adenocarcinoma and malignant melanoma by RT-PCR. Sardi I; Moretti S; Ponchietti R; Arrigucci S; Guazzelli R; Montali E Int J Mol Med; 1999 Apr; 3(4):417-9. PubMed ID: 10085416 [TBL] [Abstract][Full Text] [Related]
36. The expression of prostate-specific membrane antigen in peripheral blood leukocytes. Lintula S; Stenman UH J Urol; 1997 May; 157(5):1969-72. PubMed ID: 9112573 [TBL] [Abstract][Full Text] [Related]
37. Can the reverse transcriptase-polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen improve staging and predict biochemical recurrence? Adsan O; Cecchini MG; Bisoffi M; Wetterwald A; Klima I; Danuser HJ; Studer UE; Thalmann GN BJU Int; 2002 Oct; 90(6):579-85. PubMed ID: 12230621 [TBL] [Abstract][Full Text] [Related]
38. Molecular detection of prostate cells in ejaculate and urethral washings in men with suspected prostate cancer. Clements JA; Rohde P; Allen V; Hyland VJ; Samaratunga ML; Tilley WD; Lavin MF; Gardiner RA J Urol; 1999 Apr; 161(4):1337-43. PubMed ID: 10081904 [TBL] [Abstract][Full Text] [Related]
39. Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases. Martínez-Piñeiro L; Rios E; Martínez-Gomariz M; Pastor T; de Cabo M; Picazo ML; Palacios J; Perona R Eur Urol; 2003 Apr; 43(4):342-50. PubMed ID: 12667714 [TBL] [Abstract][Full Text] [Related]
40. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Loric S; Dumas F; Eschwege P; Blanchet P; Benoit G; Jardin A; Lacour B Clin Chem; 1995 Dec; 41(12 Pt 1):1698-704. PubMed ID: 7497608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]